changing from semaglutide to zepbound Goodbye Compounded Semaglutide: GLP-1 Switch + Menopause Weight Loss Journey Update Switch from Ozempic to Zepbound

Current diabetes guidelines recommend multifactorial CV risk management and the preferential use of a glucagon-like peptide-1 receptor agonist (GLP-1RA) or sodiumglucose cotransporter-2 inhibitor with proven CV benefits as a first choice add-on to metformin in patients with T2D and established atherosclerotic CVD [2, 4]

* This is enough to quiet the brain but low enough to avoid side effects and reduce cost

Injecting at the wrong angle

The magnitude of weight loss reported in the STEP trials offers the potential for clinically relevant improvement for individuals with obesityrelated diseases

You're not putting hormone in